Fennec Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2002 | — | $6.1M | — |
| FY2003 | — | $698.0K | — |
| FY2004 | — | $20.5M | — |
| FY2005 | — | $11.1M | — |
| FY2006 | — | $1.3M | — |
| FY2007 | — | $14.1M | — |
| FY2008 | — | $3.1M | — |
| FY2009 | — | $406.0K | $685.0K |
| FY2010 | — | $-4.9M | $5.9M |
| FY2011 | — | $-119.0K | $5.3M |
| FY2012 | — | $-5.0M | $2.3M |
| FY2013 | — | $-1.5M | $1.7M |
| FY2014 | — | $613.0K | $2.3M |
| FY2015 | — | $548.0K | $942.0K |
| FY2016 | — | $3.6M | $3.9M |
| FY2017 | — | $26.8M | $28.3M |
| FY2018 | — | $21.3M | $22.8M |
| FY2019 | — | $11.9M | $13.7M |
| FY2020 | — | $29.1M | $30.3M |
| FY2021 | — | $15.8M | $21.1M |
| FY2022 | $24.9M | $-2.6M | $23.8M |
| FY2023 | $30.9M | $9.6M | $13.3M |
| FY2024 | $19.3M | $-5.9M | $26.6M |
| FY2025 | — | $35.5M | $36.8M |